VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
+10.73%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$188M
AUM Growth
+$30.7M
(+19%)
Cap. Flow
+$19.9M
Cap. Flow
% of AUM
10.59%
Top 10 Holdings %
Top 10 Hldgs %
6.1%
Holding
495
New
69
Increased
189
Reduced
162
Closed
73
Top Buys
| 1 |
Palantir
PLTR
|
$1.01M |
| 2 |
BlackRock TCP Capital
TCPC
|
$1M |
| 3 |
Host Hotels & Resorts
HST
|
$993K |
| 4 |
DFS
Discover Financial Services
DFS
|
$989K |
| 5 |
Public Storage
PSA
|
$931K |
Top Sells
| 1 |
Burlington
BURL
|
$962K |
| 2 |
Prologis
PLD
|
$773K |
| 3 |
Booking.com
BKNG
|
$734K |
| 4 |
Eaton
ETN
|
$720K |
| 5 |
TE Connectivity
TEL
|
$708K |
Sector Composition
| 1 | Healthcare | 21.52% |
| 2 | Financials | 20.16% |
| 3 | Technology | 16.46% |
| 4 | Industrials | 8.76% |
| 5 | Energy | 7.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
Amylyx Pharmaceuticals
AMLX
$910M
| $73.4K | 0.04% |
25,849
+3,719
| +17% | +$10.6K |
|
402
TG Therapeutics
TGTX
$5.11B
| $73.2K | 0.04% |
4,815
-328
| -6% | -$4.99K |
|
403
ALX Oncology
ALXO
$65.3M
| $73.2K | 0.04% |
6,566
-453
| -6% | -$5.05K |
|
404
Novavax
NVAX
$1.28B
| $72.8K | 0.04% |
15,228
-1,043
| -6% | -$4.99K |
|
405
Relay Therapeutics
RLAY
$710M
| $72.2K | 0.04% |
8,702
-593
| -6% | -$4.92K |
|
406
Caribou Biosciences
CRBU
$174M
| $72.2K | 0.04% |
14,044
-961
| -6% | -$4.94K |
|
407
Cabaletta Bio
CABA
$155M
| $71.9K | 0.04% |
4,215
-292
| -6% | -$4.98K |
|
408
AbCellera Biologics
ABCL
$1.26B
| $71.6K | 0.04% |
15,812
-1,082
| -6% | -$4.9K |
|
409
Tango Therapeutics
TNGX
$772M
| $67.5K | 0.04% |
8,502
-584
| -6% | -$4.64K |
|
|
AGEN
410
Agenus
AGEN
$138M
| $66K | 0.04% |
5,691
-390
| -6% | -$4.52K |
|
411
Immunovant
IMVT
$2.99B
| $65.6K | 0.03% |
2,031
-143
| -7% | -$4.62K |
|
412
Alector
ALEC
$305M
| $65.2K | 0.03% |
10,829
-744
| -6% | -$4.48K |
|
413
Structure Therapeutics
GPCR
$1.27B
| $63.4K | 0.03% |
1,480
-100
| -6% | -$4.29K |
|
414
Editas Medicine
EDIT
$248M
| $59.3K | 0.03% |
7,990
-551
| -6% | -$4.09K |
|
415
Cassava Sciences
SAVA
$104M
| $58.4K | 0.03% |
2,879
-196
| -6% | -$3.98K |
|
416
uniQure
QURE
$985M
| $55.6K | 0.03% |
10,693
-737
| -6% | -$3.83K |
|
417
Prothena Corp
PRTA
$460M
| $55.1K | 0.03% |
2,223
-150
| -6% | -$3.72K |
|
418
CureVac
CVAC
$1.21B
| $45.4K | 0.02% |
14,988
-1,030
| -6% | -$3.12K |
|
419
RAPT Therapeutics
RAPT
$214M
| $40.2K | 0.02% |
560
-38
| -6% | -$2.73K |
|
|
ALLK
420
DELISTED
Allakos
ALLK
| $34.7K | 0.02% |
27,504
-1,887
| -6% | -$2.38K |
|
421
Scilex Holding
SCLX
$159M
| $26.6K | 0.01% |
504
| – | – |
|
422
Automatic Data Processing
ADP
$120B
| – | – |
-2,423
| Closed | -$564K |
|
423
Agnico Eagle Mines
AEM
$76.3B
| – | – |
-4,124
| Closed | -$226K |
|
424
Alico
ALCO
$256M
| – | – |
-7,861
| Closed | -$229K |
|
|
ALEX
425
Alexander & Baldwin
ALEX
$1.41B
| – | – |
-11,939
| Closed | -$227K |
|